IllnessSmith-Lemli-Opitz syndrome, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Smith-Lemli-Opitz syndrome comprising 1 core gene, 13 core candidate genes and altogether 29 curated genes according to the clinical signs
65,3 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[Sanger]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
CC2D2A | 4863 | NM_001080522.2 | AR | |
CEP290 | 7440 | NM_025114.4 | AR | |
DHCR7 | 1428 | NM_001360.3 | AR | |
EBP | 693 | NM_006579.3 | XL | |
KIF14 | 4947 | NM_014875.3 | AR | |
LZTR1 | 2523 | NM_006767.4 | AD, AR | |
MKS1 | 1680 | NM_017777.4 | AR | |
NPHP3 | 3993 | NM_153240.5 | AR | |
PTPN11 | 1782 | NM_002834.5 | AD | |
RPGRIP1L | 3948 | NM_015272.5 | AR | |
SOS1 | 4002 | NM_005633.4 | AD | |
TCTN2 | 2094 | NM_024809.5 | AR | |
TMEM216 | 438 | NM_001173990.3 | AR | |
TMEM67 | 2988 | NM_153704.6 | AR | |
B9D1 | 615 | NM_015681.5 | AR | |
B9D2 | 528 | NM_030578.4 | AR | |
BRAF | 2301 | NM_004333.6 | AD | |
DHCR24 | 1551 | NM_014762.4 | AR | |
FDFT1 | 1254 | NM_004462.5 | AR | |
GLI3 | 4743 | NM_000168.6 | AD | |
KRAS | 567 | NM_004985.5 | AD | |
MAP2K1 | 1182 | NM_002755.4 | AD | |
NRAS | 570 | NM_002524.5 | AD | |
RAF1 | 1947 | NM_002880.4 | AD | |
RIT1 | 660 | NM_006912.6 | AD | |
SC5D | 900 | NM_001024956.3 | AR | |
SOS2 | 3999 | NM_006939.4 | AD | |
TMEM107 | 514 | NM_032354.5 | AR | |
TMEM231 | 1110 | NM_001077416.2 | AR |
Informations about the disease
Smith-Lemli-Opitz syndrome is a complex developmental disorder with pronounced facial features, microcephaly, intellectual deficit and behavioral problems/autism as well as malformations of the heart, lungs, kidneys, gastrointestinal tract and genitals. Most patients have syndactyly, but the symptoms can vary considerably. Slightly affected persons show minor physical abnormalities with learning and behavioral problems. Severe cases can be life-threatening with profound intellectual deficits and more severe physical abnormalities.The differential diagnosis includes Meckel and Noonan syndrome, Pallister-Hall syndrome, desmosterolosis, MEND syndrome (chondrodysplasia punctata 2), squalene synthase deficiency and lathosterolosis.
(Basic diagnostic genes: ###)
Reference: https://www.ncbi.nlm.nih.gov/books/NBK1143/
- Sympt.: Polydactyly, sex reversal [in males], renal hypoplasia, unilobar lung
- Alias: 7-dehydrocholesterol reductase deficiency
- Alias: Lethal acrodysgenital syndrome
- Alias: Rutledge lethal multiple anomaly syndrome
- Alias: SLO
- Bardet-Biedl syndrome 13 (MKS1)
- Bardet-Biedl syndrome 14 (CEP290)
- Bardet-Biedl syndrome 14, modifier of (TMEM67)
- COACH syndrome 1 (TMEM67)
- COACH syndrome 2 (CC2D2A)
- COACH syndrome 3 (RPGRIP1L)
- Cardiofaciocutaneous syndrome (BRAF)
- Cardiofaciocutaneous syndrome 2 (KRAS)
- Cardiofaciocutaneous syndrome 3 (MAP2K1)
- Cardiomyopathy, dilated, 1NN (RAF1)
- Chondrodysplasia punctata, XLD (EBP)
- Desmosterolosis (DHCR24)
- Fibromatosis, gingival, 1 (SOS1)
- Greig cephalopolysyndactyly syndrome (GLI3)
- Joubert syndrome 2 (TMEM216)
- Joubert syndrome 20 (TMEM231)
- Joubert syndrome 24 (TCTN2)
- Joubert syndrome 27 (B9D1)
- Joubert syndrome 28 (MKS1)
- Joubert syndrome 29 (TMEM107)
- Joubert syndrome 34 (B9D2)
- Joubert syndrome 5 (CEP290)
- Joubert syndrome 6 (TMEM67)
- Joubert syndrome 7 (RPGRIP1L)
- Joubert syndrome 9 (CC2D2A)
- LEOPARD syndrome 1 (PTPN11)
- LEOPARD syndrome 2 (RAF1)
- LEOPARD syndrome 3 (BRAF)
- Lathosterolosis (SC5D)
- Leber congenital amaurosis 10 (CEP290)
- MEND syndrome (EBP)
- Meckel syndrome 1 (MKS1)
- Meckel syndrome 10 (B9D2)
- Meckel syndrome 11 (TMEM231)
- Meckel syndrome 12 (KIF14)
- Meckel syndrome 13 (TMEM107)
- Meckel syndrome 2 (TMEM216)
- Meckel syndrome 3 (TMEM67)
- Meckel syndrome 4 (CEP290)
- Meckel syndrome 5 (RPGRIP1L)
- Meckel syndrome 6 (CC2D2A)
- Meckel syndrome 7 (NPHP3)
- Meckel syndrome 8 (TCTN2)
- Meckel syndrome 9 (B9D1)
- Metachondromatosis (PTPN11)
- Microcephaly 20, primary, AR (KIF14)
- Nephronophthisis 11 (TMEM67)
- Nephronophthisis 3 (NPHP3)
- Noonan syndrome 1 (PTPN11)
- Noonan syndrome 10 (LZTR1)
- Noonan syndrome 2 (LZTR1)
- Noonan syndrome 3 (KRAS)
- Noonan syndrome 4 (SOS1)
- Noonan syndrome 5 (RAF1)
- Noonan syndrome 6 (NRAS)
- Noonan syndrome 7 (BRAF)
- Noonan syndrome 8 (RIT1)
- Noonan syndrome 9 (SOS2)
- Orofaciodigital syndrome XVI (TMEM107)
- Pallister-Hall syndrome (GLI3)
- Polydactyly, postaxial, types A1 + B (GLI3)
- Polydactyly, preaxial, type IV (GLI3)
- RAS-associated autoimmune leukoproliferative disorder (KRAS)
- RHYNS syndrome (TMEM67)
- Renal-hepatic-pancreatic dysplasia 1 (NPHP3)
- Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic (KRAS)
- Senior-Loken syndrome 6 (CEP290)
- Smith-Lemli-Opitz syndrome (DHCR7)
- Squalene synthase deficiency (FDFT1)
- AD
- AR
- XL
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
No text defined
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.